XML 33 R19.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

REVENUES (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
REVENUES |
Schedule of Company's Disaggregation of Revenues | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended March 31, | ​ | ​
(U.S. dollars in thousands) |  | 2024 |  | 2023 | ​ | ​
Pfizer | ​ | $ | 1,127 | ​ | $ | 2,266 | ​ | ​
Brazil | ​ | $ | 2,550 | ​ | $ | 2,800 | ​ | ​
Total revenues from selling goods | ​ | $ | 3,677 | ​ | $ | 5,066 | ​ | ​
Revenues from license and R&D services | ​ | $ | 71 | ​ | $ | 4,522 | ​ | ​
​

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration